NeoGenomics (NASDAQ:NEO) PT Raised to $47.00 at SVB Leerink

NeoGenomics (NASDAQ:NEO) had its target price boosted by equities researchers at SVB Leerink from $45.00 to $47.00 in a note issued to investors on Wednesday, AnalystRatings.net reports. The firm presently has an “outperform” rating on the medical research company’s stock. SVB Leerink’s price objective suggests a potential upside of 13.66% from the stock’s previous close.
Several other analysts also recently weighed in on NEO. ValuEngine upgraded NeoGenomics from a “hold” rating to a “buy” ratin…

Original Source